The safety assessment is based on the independent safety profiles of each compound (GLP-1 medications through extensive FDA trials, BPC-157 through decades of preclinical research), their non-overlapping mechanisms, and growing clinical experience from physicians who prescribe both
The vial always holds the same amount of peptide
Each vial meets USP specifications for sterility, endotoxin limits, and particulate matter, ensuring consistent and reliable performance in research applications
This guide covers what BPC-157 does in each area, what our patients see, and how long it takes
It is not approved for human or veterinary use and must not be incorporated into foods, pharmaceuticals, cosmetics, or diagnostic applications
Once treated, fat cells are destroyed, they do not come back